
Biliary stent combined with iodine-125 seed strand implantation in malignant obstructive jaundice
Author(s) -
Huiwen Wang,
Xiaojing Li,
Shijie Li,
Junrong Lu,
Dongfeng He
Publication year - 2021
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v9.i4.801
Subject(s) - medicine , obstructive jaundice , iodine , biliary stent , jaundice , stent , radiology , materials science , metallurgy
Malignant obstructive jaundice is mainly caused by cholangiocarcinoma. Only a few patients are indicated for surgical resection, and the 3-year survival rate is < 50%. For patients who are not eligible for surgery, biliary stent placement can relieve biliary obstruction and improve liver function and quality of life. However, restenosis after biliary stents has a poor prognosis and is a clinical challenge. Biliary stent combined with iodine-125 ( 125 I) seed implantation can prolong stent patency and improve survival.